Startups

Life Science blunders
First Opinion

5 top blunders life science startups make on the road to clinical trials

By Laurie Halloran

Elizabeth Holmes
First Opinion

Investing in a startup? Follow the data, not the herd

By Swati Chaturvedi

Tyler Jacks biotech
Business

Researchers take the plunge into industry — without leaving the ivory tower

By Andrew Joseph

Business

Startup Editas plans to test IPO market for biotechs

By Robert Weisman — Boston Globe

Business

Executives-for-hire help biotech startups get off the ground

By Andrew Joseph

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy